XIV International symposium. Controversies in Glaucoma: focus on Comorbidities

About symposium

Dear colleagues, we invite you to take part in the XIV International Webinar: «Controversies in Glaucoma: focus on Comorbidities », which will be held on November,7 at 3 p.m. (Moscow time).

Glaucoma, being one of the leading causes of blindness in the world and affects the patients with different comorbidities. It is evident that we need a shift to the personalised medicine as a new philosophy covering both "health care" and "disease care", promoting an integrated approach combining advantages of individual biomedical fields and technologies and consolidating a multi-professional collaboration.

This year, the symposium will feature leading international experts from Brazil (R. Susanna, V. Costa), China (X. Zhan), USA (K. Chan), Kazakhstan (K. Urikh), and Russia (A. Fursova, N. Serova, R. Faizrakhmanov, N. Kurysheva). The author and coordinator of the project is Prof. N.I. Kurysheva. The moderators of the teleconference are Prof. N.I. Kurysheva and Prof. R.R. Faizrakhmanov.

Download the program (PDF)

Reporter

Remo Susanna Jr.

Brazil

Founder and served as president of the Latin America Glaucoma Society from 2000 to 2008. Served as governor of the Association of International Glaucoma Societies from 2001 to 2003. Ex-President of the Pan American Glaucoma Society and Past president of the World Glaucoma Association. He has authored and edited nine books, 32 book chapters and over 280 papers on glaucoma. He has served on the editorial board of three ophthalmic journals and is a reviewer for numerous journals including British Journal of Ophthalmology, Archives of Ophthalmology, and Journal of Glaucoma. Has a patent for the Susanna implant for the treatment of glaucoma, the implant most commonly used in Brazil. The driving force behind the creation of programs in Brazil that provide free cataract surgery, glaucoma treatment and eye care for children from disadvantaged families. He developed the Early Diagnostic Program based in stereo-photographs launch ed in Europe and Asia, considered one of the best programs to teach physicians to diagnose glaucoma optic neuropathy

Kevin C. Chan

USA

Kevin C. Chan, Ph.D. is an Associate Professor of Ophthalmology and the Director of the Neuroimaging and Visual Science Laboratory at Stanford University School of Medicine. His laboratory focuses on developing and applying new, non-invasive methods for imaging neurodegeneration, neurodevelopment, neuroprotection, neuroplasticity, and neuroregeneration in vision-related diseases and injuries to guide vision preservation and restoration. Dr. Chan has over 15 years of experience in structural, metabolic, physiological, and functional magnetic resonance imaging (MRI) research on the eye and brain of human and animal models of glaucoma and other visual impairments. His team combines the use of optical coherence tomography, MRI, neuromodulation, and psychophysical assessments to determine the processes underlying the interplay among eye, brain, and behavior in health and disease.

Xianquan Zhan

China

Dr. Xianquan Zhan is a Professor of Clinical Proteomics and Structural Biology at Xiangya Hospital of Central South University in China, Supervisor of MS/PhD graduate students and postdoctoral fellows, Fellow of Royal Society of Medicine (FRSM), AAAS member, European EPMA National Representative in China, Editor-In-Chief of International Journal of Chronic Diseases & Therapy, Associate Editors of BMC Medical Genomics, EPMA Journal, and Frontiers in Endocrinology, and Editorial Board Members of 62 international journals. He has published 120 peer-reviewed research articles (85 articles in the field of disease proteomics and transcriptomics), 14 book chapters, and 2 US patents. He focuses on the studies of cancer proteomics and biomarkers, and the use of multi-omics in personalized medicine.

Urich Konstantin

Kazakhstan

Lead surgeon of the clinic, ophthalmic surgeon of the highest category, Candidate of Medical Sciences. Member of ESCRS (European Society of Cataract and Refractive Surgeons), RSCRS (Russian Society of Cataract and Refractive Surgeons), RGS (Russian Glaucoma Society), the National Expert Council on the Diagnosis and Treatment of "Red Eye" Syndromes, the Ophthalmological Society of Astana, and the Kazakhstan Ophthalmological Society. He has 16 years of professional experience. Dr. [Name] is also a member of EuRetina and currently serves as Deputy Director of Optima Clinic and Chair of the Astana branch of the Kazakhstan Ophthalmological Society.

Vital P. Costa

Brazil

MD, associate prof. of the Department of Ophthalmology and Otorhinolaryngology university of Campinas UNICAMP and head of postgraduate education department. Headed the Brazilian scientific society of glaucoma and the Ibero-American society of glaucoma.

Fursova Anzhella

Russia

Doctor of Medical Sciences, Honored Physician of the Russian Federation, Chief Ophthalmologist of Novosibirsk region and Chief Pediatric Ophthalmologist of Novosibirsk region, Head of the Ophthalmology Department at the State Novosibirsk Regional Clinical Hospital, Head of the Department of Ophthalmology at Novosibirsk State Medical University. Excellent Health Worker of the Russian Federation. Professional experience—more than 36 years. Member of the Expert Council for Retinal Pathology at the Russian Ophthalmologists Association, board member of the Novosibirsk branch of the interregional association of ophthalmologists, secretary of the regional ophthalmological commission for awarding qualification categories. Speaker and participant of leading European and international congresses in cataract and glaucoma surgery (ESCRS, Euroretina), "White Nights" seminars, and professional associations. Author of more than 200 scientific articles, including publications in central Russian and international journals, and holder of patents for new treatment approaches for retinal and optic nerve diseases. Implements innovative strategies for age-related macular degeneration and retinal pathologies, actively engaged in research projects and educational activities. Awarded honorary diplomas by the Governor of Novosibirsk region (2004, 2007, 2008), the Ministry of Health of the Russian Federation (2008, 2009), the "Doctor of the Year" title as an ophthalmologist (2004, 2010), "Excellent Health Worker of the Russian Federation" (2014), and "Honored Physician of Russia" (2017). Research interests: ophthalmology, cataract and glaucoma surgery, retinal pathology, vascular pathology of the fundus, traumatic eye injuries, age-related macular degeneration, innovative methods of treatment and diagnostics, healthcare organization in ophthalmology, personalized approaches in eye disease therapy.

Serova Natalya

Russia

Doctor of Medical Sciences, Professor, leading neuro-ophthalmologist of the Russian Federation, Professor at the Department of Ophthalmology, Chief Researcher and Head of the Neuro-Ophthalmology Group at the N.N. Burdenko National Medical Research Center for Neurosurgery, Ministry of Health of Russia (Moscow). In 2003, Natalya Konstantinovna Serova was awarded the academic title of Professor, and in 2004 she received the honorary title “Honored Healthcare Worker of the Russian Federation.” She is a member of the Presidium of the Russian Society of Ophthalmologists. Professor Serova is the author of more than 179 scientific publications. She serves on the editorial boards of several leading specialized journals, including Russian Children’s Ophthalmology, Russian Pediatric Ophthalmology, Questions of Neurosurgery named after N.N. Burdenko, and Vestnik Ophthalmologii (Journal of Ophthalmology). She has been the organizer of the annual All-Russian Conferences on Neuro-Ophthalmology (since 1996) and served as President of the European Neuro-Ophthalmology Congress (Moscow, 2005). Under her supervision, more than 10 PhD and doctoral dissertations have been defended. Her scientific interests include neuro-ophthalmology, pathology of the optic nerve and retina, ophthalmic surgery, development of the neuro-ophthalmological care system in Russia, innovative methods of diagnosis and therapy, and professional training of specialists.

Faizrakhmanov Rinat

Russia

Doctor of Medical Sciences, Professor, Head of the Ophthalmology Center at the National Medical Research Center of Surgery named after N.I. Pirogov, Ministry of Health of Russia (Moscow), and Head of the Department of Ophthalmology at the Institute of Advanced Medical Training. Corresponding member of the Russian Academy of Natural Sciences, member of the Presidium of the Board of the Russian Society of Ophthalmologists, and member of the European Society of Vitreoretinal Surgeons (Euretina). Professor Faizrakhmanov is the author of more than 150 scientific publications, holds 18 invention patents, 3 intellectual property products, 2 rationalization proposals, and a number of clinical guidelines for practicing physicians. In 2020, he was honored with a Commendation from the Minister of Health of the Russian Federation. His main scientific and clinical interests include modern methods for the treatment of retinal detachment, proliferative diabetic retinopathy, macular pathology, microinvasive vitreoretinal surgery, phacoemulsification of cataracts with implantation of various intraocular lens models, reconstructive surgery after trauma, intravitreal drug administration, and macular surgery. Under his leadership, the Ophthalmology Center and department have become leading educational and clinical platforms in the country, focused on implementing innovative approaches and advanced standards in ophthalmology.

Natalia I. Kurysheva

Russia

Dr. of Medical Sciences, Head of the Department of Eye Diseases of the Federal Medical and Biological University of Innovations and Continuing Education of the FMBA of Russia; Professor of the Department of Ophthalmology of the APO of the FSBI FNCC of the FMBA of Russia; Head of the Consultative and Diagnostic Department of the Center of Ophthalmology of the FMBA of Russia; a member of the European Glaucoma Society and the American Academy of Ophthalmology; honorary member of the Italian Glaucoma Society; scientific supervisor and coordinator of the Federal Target Group Programs «Glaucoma Opticoneuropathy». Natalia is a representative of Russian Ophthalmology in the European Association of Predictive, Preventive and Personalized Medicine. The research interests: etiology, pathogenesis, laser and surgical treatment of glaucoma, neuroprotection, angle-closure, normotensive and pseudoexfoliative glaucoma, retinal diseases. For the last 10 years, she has been studying new methods of optic nerve and retina visualization in glaucoma, the progression of the disease, and ocular blood flow and the personalized treatment of the primary angle clouser. Author of more than 300 scientific papers, including 50 papers in international peer-reviewed journals, 10 monographs on the diagnosis and treatment of glaucoma and ocular blood flow, as well as 10 patents for inventions. Member of the editorial board of the National Journal of Glaucoma (Russia) and Ophthalmology Journal (Russia), a reviewer of the British Journal of Ophthalmology (BJO), Bulletin of Ophthalmology and other prominent international journals. She was awarded by the Ministry of Education of the Russian Federation for scientific research on topical issues of fundamental and applied science in the field of education, achievements in the training of highly qualified specialists, for the introduction of new forms and methods of teaching in the educational process. The author of two recent monographs: COVID-19 and visual organ damage, 2021, and Dry age-related macular degenerations, 2021, a member of International Optical Circulation Society (IOCS).

Program

November 7, 2025

15.00 - 15.05

Opening of the webinar

15.05 - 15.20

The philosophy of comorbidity in glaucoma patients: what determines priorities?

Fursova Anzhella, Russia

15.05 - 15.20

15.20 - 15.35

Mitochondrial medicine: "from bench to bedside" 3PM-guided concept

Xianquan Zhan, China

15.20 - 15.35

15.35 - 15.55

Metabolomics and neuroprotective treatment in patients with comorbid pathology

Kurysheva N., Russia

15.35 - 15.55

15.55 - 16.15

Glaucomatous and other types of optic neuropathies: differential approach in diagnosis and monitoring

Serova Natalya, Russia

15.55 - 16.15

16.15 - 16.30

Hypothalamic impairments and glaucoma patients

Kevin C. Chan, USA

16.15 - 16.30

16.30 - 16.45

The role of angiogenesis inhibitors in the treatment of comorbid pathology

Faizrakhmanov Rinat, Russia

16.30 - 16.45

16.45 - 17.05

IOP Fluctuation, Peak or Mean: in patients with coexisting glaucoma and myopia and What Matters Most in Glaucoma Progression?

Remo Susanna Jr., Brazil

16.45 - 17.05

17.05 - 17.25

New options in the monitoring and treatment of comorbid diseases

Kurysheva N., Russia

17.05 - 17.25

17.25 - 17.45

Ocular perfusion pressure in glaucoma: how should we treat the patients with systemic hypertension

, Brazil

17.25 - 17.45

17.45 - 18.00

Personalized approach to the treatment and monitoring of patients with glaucoma and comorbid diseases

Urich Konstantin, Kazakhstan

17.45 - 18.00

18.00 - 18.15

XIV International symposium
Controversies in Glaucoma: focus on Comorbidities

About symposium

Reporter

Program

Opening of the webinar

The philosophy of comorbidity in glaucoma patients: what determines priorities?

Mitochondrial medicine: "from bench to bedside" 3PM-guided concept

Metabolomics and neuroprotective treatment in patients with comorbid pathology

Glaucomatous and other types of optic neuropathies: differential approach in diagnosis and monitoring

Hypothalamic impairments and glaucoma patients

The role of angiogenesis inhibitors in the treatment of comorbid pathology

IOP Fluctuation, Peak or Mean: in patients with coexisting glaucoma and myopia and What Matters Most in Glaucoma Progression?

New options in the monitoring and treatment of comorbid diseases

Ocular perfusion pressure in glaucoma: how should we treat the patients with systemic hypertension

Personalized approach to the treatment and monitoring of patients with glaucoma and comorbid diseases

Discussion and summing up the results of the webinar

Information partners